Cargando…
Nanomedicine-Based Neuroprotective Strategies in Patient Specific-iPSC and Personalized Medicine
In recent decades, nanotechnology has attracted major interests in view of drug delivery systems and therapies against diseases, such as cancer, neurodegenerative diseases, and many others. Nanotechnology provides the opportunity for nanoscale particles or molecules (so called “Nanomedicine”) to be...
Autores principales: | Jang, Shih-Fan, Liu, Wei-Hsiu, Song, Wen-Shin, Chiang, Kuan-Lin, Ma, Hsin-I, Kao, Chung-Lan, Chen, Ming-Teh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975375/ https://www.ncbi.nlm.nih.gov/pubmed/24599081 http://dx.doi.org/10.3390/ijms15033904 |
Ejemplares similares
-
Engineering considerations of iPSC-based personalized medicine
por: Park, Sangbae, et al.
Publicado: (2023) -
Inhibition of Arachidonate 12/15-Lipoxygenase Improves α-Galactosidase Efficacy in iPSC-Derived Cardiomyocytes from Fabry Patients
por: Chien, Yueh, et al.
Publicado: (2018) -
Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders
por: Gurwitz, David
Publicado: (2016) -
iPSC technology-based regenerative medicine for kidney diseases
por: Osafune, Kenji
Publicado: (2021) -
iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology
por: Turhan, Ali G., et al.
Publicado: (2021)